Citigroup’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$371K Buy
23,975
+6,038
+34% +$93.3K ﹤0.01% 3080
2025
Q1
$267K Sell
17,937
-8,059
-31% -$120K ﹤0.01% 3270
2024
Q4
$344K Buy
25,996
+3,159
+14% +$41.8K ﹤0.01% 3249
2024
Q3
$325K Sell
22,837
-4,676
-17% -$66.5K ﹤0.01% 3268
2024
Q2
$356K Sell
27,513
-26,746
-49% -$346K ﹤0.01% 2889
2024
Q1
$754K Buy
54,259
+6,283
+13% +$87.3K ﹤0.01% 2571
2023
Q4
$685K Sell
47,976
-9,965
-17% -$142K ﹤0.01% 2457
2023
Q3
$896K Buy
57,941
+3,089
+6% +$47.8K ﹤0.01% 1995
2023
Q2
$862K Buy
54,852
+1,285
+2% +$20.2K ﹤0.01% 2351
2023
Q1
$883K Buy
53,567
+2,436
+5% +$40.1K ﹤0.01% 2110
2022
Q4
$798K Sell
51,131
-891
-2% -$13.9K ﹤0.01% 2221
2022
Q3
$674K Sell
52,022
-883
-2% -$11.4K ﹤0.01% 2384
2022
Q2
$743K Sell
52,905
-13,429
-20% -$189K ﹤0.01% 2313
2022
Q1
$950K Sell
66,334
-7,723,759
-99% -$111M ﹤0.01% 2393
2021
Q4
$106M Buy
7,790,093
+4,920,375
+171% +$67.1M 0.06% 198
2021
Q3
$47M Buy
2,869,718
+2,120,154
+283% +$34.7M 0.03% 389
2021
Q2
$12.6M Buy
749,564
+493,941
+193% +$8.31M 0.01% 945
2021
Q1
$4.67M Sell
255,623
-36,926
-13% -$674K ﹤0.01% 1368
2020
Q4
$5.33M Sell
292,549
-964,253
-77% -$17.6M ﹤0.01% 1232
2020
Q3
$22.4M Buy
1,256,802
+249,083
+25% +$4.44M 0.01% 530
2020
Q2
$18.1M Sell
1,007,719
-19,658
-2% -$352K 0.01% 544
2020
Q1
$15.6M Buy
1,027,377
+768,416
+297% +$11.7M 0.01% 505
2019
Q4
$5.11M Buy
258,961
+74,915
+41% +$1.48M ﹤0.01% 1126
2019
Q3
$3.17M Buy
184,046
+9,527
+5% +$164K ﹤0.01% 1307
2019
Q2
$3.09M Sell
174,519
-70,636
-29% -$1.25M ﹤0.01% 1345
2019
Q1
$4.99M Sell
245,155
-6,303,151
-96% -$128M ﹤0.01% 1003
2018
Q4
$113M Buy
+6,548,306
New +$113M 0.11% 89